This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
EXPAND-TB (Expanding Access to New Diagnostics for TB) is a UNITAID-funded project launched in 2009, which aims to increase access to tuberculosis (TB) diagnostic tests in 27 endemic countries.[1][2]
The overall goal of the project is to narrow the huge diagnostic gap in multi-drug-resistant tuberculosis (MDR-TB) control by expanding and accelerating access to new and rapid diagnostic technologies within appropriate laboratory services, accompanied by the necessary technology transfer, and ensuring these new technologies are properly integrated within TB control programmes.[3][4][5]
Main Partners edit
- UNITAID
- World Health Organization (WHO)
- Foundation for Innovative New Diagnostics
- Stop TB Partnership Global Laboratory Initiative (GLI)
- Stop TB Partnership Global Drug Facility (GDF)
References edit
- ^ "FIND - About the EXPAND-TB project". Archived from the original on 2011-10-02. Retrieved 2011-04-06.
- ^ "Stop TB Partnership - Boosted EXPAND-TB agreement will broaden access to MDR-TB diagnosis". www.stoptb.org. Archived from the original on 2010-11-30. Retrieved 2011-04-06.
- ^ "Assets" (PDF). www.stoptb.org.
- ^ "Documents" (PDF). www.stoptb.org.
- ^ "Expanding and accelerating access to diagnostics for patients at risk of MDR-TB". Archived from the original on 2011-07-24. Retrieved 2011-04-06.